MyFinsight
Home
Blog
About
Revenue From Contract
With Customer...
$1,156,100K
(17.30%↑ Y/Y)
Product And Services
Product Sales Net Of...
$1,156,100K
(17.30%↑ Y/Y)
High Sodium
AGOxybate Product Royalty...
$42,200K
(-22.05%↓ Y/Y)
Other Royalty And
Contract Revenues
$10,000K
Total revenues
$1,208,300K
(15.55%↑ Y/Y)
Income (gain) from
operations
$248,200K
(136.16%↑ Y/Y)
Total operating
expenses
$960,100K
(-44.57%↓ Y/Y)
Income (gain) before
income tax expense...
$211,000K
(128.69%↑ Y/Y)
Interest expense, net
-$37,100K
(21.67%↑ Y/Y)
Foreign exchange gain
(loss)
-$100K
(94.44%↑ Y/Y)
Selling, general and
administrative
$389,200K
(8.59%↑ Y/Y)
Research and development
$207,500K
(9.23%↑ Y/Y)
Intangible asset
amortization
$170,000K
(4.87%↑ Y/Y)
Cost of product sales
(excluding amortization of...
$116,400K
(0.11%↑ Y/Y)
Acquired in-process
research and development
$77,000K
(-91.50%↓ Y/Y)
Net income (gain)
$192,800K
(126.83%↑ Y/Y)
Income tax expense
(benefit)
$18,100K
(205.42%↑ Y/Y)
Equity in loss of
investees
-$100K
(-16.28%↓ Y/Y)
Back
Back
Income Statement
Jazz Pharmaceuticals plc (JAZZ)
Jazz Pharmaceuticals plc (JAZZ)
source: myfinsight.com